+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bursitis Treatment Market - Global Forecast 2025-2030- Product Image
Bursitis Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Bursitis Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977993
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bursitis treatment market is advancing rapidly as healthcare systems prioritize dynamic, patient-centered solutions and innovative therapies to improve musculoskeletal care. Leaders navigating this space must stay alert to evolving strategies and shifting regulatory landscapes to secure patient access and operational resilience.

Market Snapshot: Bursitis Treatment Market Size and Growth

The bursitis treatment market grew from USD 8.14 billion in 2024 to USD 8.54 billion in 2025. It is projected to expand at a 4.65% CAGR, reaching USD 10.70 billion by 2030. Strong demand stems from aging demographics, growing rates of physical activity, and the need for more tailored care. A surge in digital health adoption, regenerative therapeutics, and operational shifts further influences value creation and competitive advantage within the sector.

Scope & Segmentation

This research report investigates the depth and breadth of the bursitis treatment market, focusing on product innovation, care delivery models, and region-specific trends. Segmentation captures the diversity of treatment modalities, technology adoption, and end-user environments, ensuring actionable insights for executives.

  • Treatment Types: Home care interventions (including ice therapy, rest immobilization, warm compresses), injectable therapies (corticosteroid, hyaluronic acid, platelet-rich plasma), oral medications (over-the-counter and prescription nonsteroidal anti-inflammatory drugs), physical therapy (cryotherapy, structured exercise, manual techniques), and surgical interventions (arthroscopic, open surgery).
  • Product Categories: Antibiotics, biologics, corticosteroids, nonsteroidal anti-inflammatory drugs.
  • Anatomical Application Sites: Elbow, heel, hip, knee, and shoulder.
  • End Users: Ambulatory surgical centers, home care, hospitals, orthopedic clinics, sports medicine facilities.
  • Geographic Regions: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (covering major countries in Western Europe, the Middle East, Africa), Asia-Pacific (notably China, India, Japan, Australia, and several Southeast Asian markets).
  • Leading Companies: Pfizer Inc., Bayer AG, Johnson & Johnson, Novartis AG, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Sanofi S.A., Merck & Co., Inc., Zimmer Biomet Holdings, Inc., and Stryker Corporation.

Bursitis Treatment Market: Key Takeaways for Senior Decision-Makers

  • Customized, patient-centric pathways are replacing standardized protocols, resulting in improved long-term outcomes and elevated patient satisfaction across clinical environments.
  • Integration of biologic and regenerative medicine therapies provides alternatives to systemic treatments, particularly for cases unresponsive to conventional care.
  • Digital health platforms and wearable sensors are gaining traction, allowing providers to deliver continuous care, adjust therapy regimens, and enhance adherence remotely.
  • Multidisciplinary collaboration among orthopedic specialists, rheumatologists, and rehabilitation professionals is driving the creation of comprehensive treatment models for complex cases.
  • Industry leaders adopt corporate partnerships and licensing agreements to accelerate development cycles and expand portfolios in response to shifting market demand.
  • Strategic investments in supply chain digitalization and analytics improve operational resilience, especially in the face of external cost or regulatory disruptions.

Impact of 2025 United States Tariffs on Bursitis Treatment Supply Chain and Economics

Tariffs implemented in 2025 affected import costs for medical components and pharmaceuticals, compelling manufacturers and distributors to revisit sourcing and procurement strategies. This led to cost recalibrations and exploration of alternative suppliers. Health providers responded with bulk procurement and group purchasing to manage expenses, while insurers refined reimbursement policies to protect accessibility and innovation. These responses reflect the market's agile adaptation to policy shifts, reinforcing the importance of resilient, flexible supply networks.

Methodology & Data Sources

This study employs a rigorous, multi-source research approach, incorporating in-depth interviews with clinical experts, analysis of peer-reviewed publications, regulatory filings, and real-world evidence from health records. Data were validated through triangulation and peer review by subject matter advisors, ensuring robust, actionable findings.

Why This Report Matters

  • Equips decision-makers with strategic clarity to navigate complex regulatory, reimbursement, and innovation trends in bursitis care.
  • Enables identification of high-value segments, emerging therapies, and partnership opportunities for competitive advantage and patient impact.
  • Supports operational planning with reliable forecasts, segmentation analyses, and validated insights for investment and go-to-market strategy.

Conclusion

Bursitis treatment is at a pivotal point, shaped by technological advancement, policy changes, and evolving patient needs. Senior leaders who leverage these insights are well-positioned to drive innovation, optimize care, and enhance their competitive standing in a dynamic landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising use of ultrasound-guided corticosteroid injections to improve bursitis treatment precision
5.2. Expansion of minimally invasive needle fenestration techniques to accelerate bursa healing and reduce recovery time
5.3. Development of novel hyaluronic acid formulations targeting shoulder and hip bursitis pain relief with longer duration
5.4. Integration of wearable motion sensors for real-time monitoring of joint stress in bursitis rehabilitation protocols
5.5. Increasing interest in platelet-rich plasma therapies for refractory bursitis cases among sports medicine practitioners
5.6. Growth of home-use cold compression systems enhanced by smart temperature control to manage bursitis inflammation
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bursitis Treatment Market, by Treatment Type
8.1. Introduction
8.2. Home Care
8.2.1. Ice Therapy
8.2.2. Rest Immobilization
8.2.3. Warm Compress
8.3. Injectable Therapy
8.3.1. Corticosteroid Injections
8.3.2. Hyaluronic Acid Injections
8.3.3. Platelet-Rich Plasma Therapy
8.4. Oral Medication
8.4.1. Over-The-Counter Nonsteroidal Anti-Inflammatory Drugs
8.4.2. Prescription Nonsteroidal Anti-Inflammatory Drugs
8.5. Physical Therapy
8.5.1. Cryotherapy
8.5.2. Exercise Therapy
8.5.3. Manual Therapy
8.6. Surgical Intervention
8.6.1. Arthroscopic Surgery
8.6.2. Open Surgery
9. Bursitis Treatment Market, by Product Category
9.1. Introduction
9.2. Antibiotics
9.3. Biologics
9.4. Corticosteroids
9.5. Nonsteroidal Anti-Inflammatory Drugs
10. Bursitis Treatment Market, by Application Site
10.1. Introduction
10.2. Elbow
10.3. Heel
10.4. Hip
10.5. Knee
10.6. Shoulder
11. Bursitis Treatment Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Home Care Settings
11.4. Hospitals
11.5. Orthopedic Clinics
11.6. Sports Medicine Centers
12. Americas Bursitis Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Bursitis Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Bursitis Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Pfizer Inc.
15.3.2. Bayer AG
15.3.3. Johnson & Johnson
15.3.4. Novartis AG
15.3.5. Teva Pharmaceutical Industries Ltd.
15.3.6. GlaxoSmithKline plc
15.3.7. Sanofi S.A.
15.3.8. Merck & Co., Inc.
15.3.9. Zimmer Biomet Holdings, Inc.
15.3.10. Stryker Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BURSITIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BURSITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BURSITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BURSITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BURSITIS TREATMENT MARKET: RESEARCHAI
FIGURE 24. BURSITIS TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. BURSITIS TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. BURSITIS TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BURSITIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BURSITIS TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BURSITIS TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ICE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ICE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REST IMMOBILIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REST IMMOBILIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY WARM COMPRESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY WARM COMPRESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CORTICOSTEROID INJECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CORTICOSTEROID INJECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HYALURONIC ACID INJECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HYALURONIC ACID INJECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PLATELET-RICH PLASMA THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PLATELET-RICH PLASMA THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PRESCRIPTION NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PRESCRIPTION NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CRYOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CRYOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY EXERCISE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY EXERCISE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY MANUAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY MANUAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ARTHROSCOPIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ARTHROSCOPIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ELBOW, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ELBOW, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HEEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HEEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HIP, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HIP, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY KNEE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY KNEE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SHOULDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SHOULDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SPORTS MEDICINE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SPORTS MEDICINE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 134. CANADA BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 135. CANADA BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2024 (USD MILLION)
TABLE 136. CANADA BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2025-2030 (USD MILLION)
TABLE 137. CANADA BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2024 (USD MILLION)
TABLE 138. CANADA BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2025-2030 (USD MILLION)
TABLE 139. CANADA BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 140. CANADA BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 141. CANADA BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 142. CANADA BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 143. CANADA BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 144. CANADA BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 145. CANADA BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2024 (USD MILLION)
TABLE 146. CANADA BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2025-2030 (USD MILLION)
TABLE 147. CANADA BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. CANADA BURSITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. MEXICO BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 158. MEXICO BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 159. MEXICO BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 160. MEXICO BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 161. MEXICO BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 163. MEXICO BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. MEXICO BURSITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. GERMANY BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 242. GERMANY BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 244. GERMANY BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 245. GERMANY BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2024 (USD MILLION)
TABLE 246. GERMANY BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2025-2030 (USD MILLION)
TABLE 247. GERMANY BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2024 (USD MILLION)
TABLE 248. GERMANY BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2025-2030 (USD MILLION)
TABLE 249. GERMANY BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 250. GERMANY BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 251. GERMANY BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 252. GERMANY BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 253. GERMANY BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 254. GERMANY BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 255. GERMANY BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2024 (USD MILLION)
TABLE 256. GERMANY BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2025-2030 (USD MILLION)
TABLE 257. GERMANY BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. GERMANY BURSITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. FRANCE BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 260. FRANCE BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 261. FRANCE BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 262. FRANCE BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 263. FRANCE BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2024 (USD MILLION)
TABLE 264. FRANCE BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2025-2030 (USD MILLION)
TABLE 265. FRANCE BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2024 (USD MILLION)
TABLE 266. FRANCE BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2025-2030 (USD MILLION)
TABLE 267. FRANCE BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 268. FRANCE BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 269. FRANCE BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 270. FRANCE BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 271. FRANCE BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 272. FRANCE BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 273. FRANCE BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2024 (USD MILLION)
TABLE 274. FRANCE BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2025-2030 (USD MILLION)
TABLE 275. FRANCE BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. FRANCE BURSITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. ITALY BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 296. ITALY BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 297. ITALY BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 298. ITALY BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 299. ITALY BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2024 (USD MILLION)
TABLE 300. ITALY BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2025-2030 (USD MILLION)
TABLE 301. ITALY BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2024 (USD MILLION)
TABLE 302. ITALY BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2025-2030 (USD MILLION)
TABLE 303. ITALY BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 304. ITALY BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 305. ITALY BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 306. ITALY BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 307. ITALY BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 308. ITALY BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 309. ITALY BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2024 (USD MILLION)
TABLE 310. ITALY BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2025-2030 (USD MILLION)
TABLE 311. ITALY BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. ITALY BURSITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. SPAIN BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 314. SPAIN BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 315. SPAIN BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 316. SPAIN BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 317. SPAIN BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2024 (USD MILLION)
TABLE 318. SPAIN BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2025-2030 (USD MILLION)
TABLE 319. SPAIN BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2024 (USD MILLION)
TABLE 320. SPAIN BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2025-2030 (USD MILLION)
TABLE 321. SPAIN BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 322. SPAIN BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 323. SPAIN BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 324. SPAIN BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 325. SPAIN BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 326. SPAIN BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 327. SPAIN BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2024 (USD MILLION)
TABLE 328. SPAIN BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2025-2030 (USD MILLION)
TABLE 329. SPAIN BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. SPAIN BURSITIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 335.

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Bursitis Treatment market report include:
  • Pfizer Inc.
  • Bayer AG
  • Johnson & Johnson
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.54 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.7 Billion
Compound Annual Growth Rate4.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Knee Bursitis Market Report 2025 - Product Image

Knee Bursitis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Repetitive Strain Injury (RSI) Treatment Market Report 2025 - Product Image

Repetitive Strain Injury (RSI) Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Essentials of Physical Medicine and Rehabilitation. Musculoskeletal Disorders, Pain, and Rehabilitation. Edition No. 4 - Product Image

Essentials of Physical Medicine and Rehabilitation. Musculoskeletal Disorders, Pain, and Rehabilitation. Edition No. 4

  • Book
Anti-Rheumatics Market - Global Forecast 2025-2030 - Product Image

Anti-Rheumatics Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Rotator Cuff Injury Treatment Market - Global Forecast 2025-2030 - Product Image

Rotator Cuff Injury Treatment Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From

About the Bursitis Drug Market

The Bursitis Drug market is a segment of the Musculoskeletal Disorders Drugs market. Bursitis is a condition that causes inflammation of the bursae, which are small sacs of fluid that cushion the joints. Treatment for bursitis typically involves the use of non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. In some cases, surgery may be necessary. The Musculoskeletal Disorders Drugs market is a large and growing market, driven by an aging population and increasing prevalence of musculoskeletal disorders. The market is expected to continue to grow in the coming years, driven by the increasing prevalence of musculoskeletal disorders and the development of new treatments. Some companies in the Bursitis Drug market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.